https://m2.mtmt.hu/ hun 2026-09-22 12:28 JournalArticle 34010976 VALIDATED true 0 false 2026-08-25T18:03:47.323+0000 2023-07-18T11:18:52.664+0000 2023-06-12T10:49:40.918+0000 true 10015206 Áncsán Gizella /api/admin/10015206 Admin Áncsán Gizella (SE admin) true 10015206 2024-12-13T12:40:19.353+0000 2024-12-13T12:40:19.353+0000 2023-07-13T12:24:18.005+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Šebeková, Katarína true true /api/journal/10052535 REVIEWED ANTIOXIDANTS 2076-3921 true false 10052535 false 10052535 true 2076-3921 Journal FOREIGN 12 6 1221 1221 19 2023 Oxidative stress and sterile inflammation play roles in the induction and maintenance of metabolic syndrome (MetS). This study cohort included 170 females aged 40 to 45 years who were categorized according to the presentation of MetS components (e.g., central obesity, insulin resistance, atherogenic dyslipidemia, and elevated systolic blood pressure) as controls not presenting a single component (n = 43), those with pre-MetS displaying one to two components (n = 70), and females manifesting MetS, e.g., ≥3 components (n = 53). We analyzed the trends of seventeen oxidative and nine inflammatory status markers across three clinical categories. A multivariate regression of selected oxidative status and inflammatory markers on the components of MetS was performed. Markers of oxidative damage (malondialdehyde and advanced-glycation-end-products-associated fluorescence of plasma) were similar across the groups. Healthy controls displayed lower uricemia and higher bilirubinemia than females with MetS; and lower leukocyte counts, concentrations of C-reactive protein, interleukine-6, and higher levels of carotenoids/lipids and soluble receptors for advanced glycation end-products than those with pre-MetS and MetS. In multivariate regression models, levels of C-reactive protein, uric acid, and interleukine-6 were consistently associated with MetS components, although the impacts of single markers differed. Our data suggest that a proinflammatory imbalance precedes the manifestation of MetS, while an imbalance of oxidative status accompanies overt MetS. Further studies are needed to elucidate whether determining markers beyond traditional ones could help improve the prognosis of subjects at an early stage of MetS. true 2023 true true true false true false GOLD 2026-08-25 true https://doi.org/10.3390/antiox12061221 13 0 13 12 0 13 12 11 10 12 12 11 11 12 1 0 13 12 13 12 0 0 0 Folyóiratcikk Journal Article 24 13 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 2 1 2 1 2024 0 2 2 2 2 2025 0 4 4 4 4 2026 0 5 5 5 5 D1 false false false false 2023-07-12T12:24:17.738+0000 Gyógyszerhatástani Intézet (SE / GYTK) 2 7 1 14 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 108966013 /api/authorship/108966013 Šebeková, Katarína ✉ 1 0.071 true false true Šebeková Katarína true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966014 /api/authorship/108966014 Staruchová, Marta 2 0.071428575 false false false Staruchová Marta true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966015 /api/authorship/108966015 Mišľanová, Csilla 3 0.071428575 false false false Mišľanová Csilla true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966016 /api/authorship/108966016 Líšková, Aurélia 4 0.071428575 false false false Líšková Aurélia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966017 /api/authorship/108966017 Horváthová, Mira 5 0.071428575 false false false Horváthová Mira true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966018 /api/authorship/108966018 Tulinská, Jana 6 0.071428575 false false false Tulinská Jana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966019 /api/authorship/108966019 Lehotská Mikušová, Miroslava 7 0.071428575 false false false Lehotská Mikušová Miroslava true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966020 /api/authorship/108966020 Szabová, Michaela 8 0.071428575 false false false Szabová Michaela true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966021 /api/authorship/108966021 Gurecká, Radana 9 0.071428575 false false false Gurecká Radana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966022 /api/authorship/108966022 Koborová, Ivana 10 0.071428575 false false false Koborová Ivana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966023 /api/authorship/108966023 Csongová, Melinda 11 0.071428575 false false false Csongová Melinda true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966024 /api/authorship/108966024 Tábi, Tamás [Tábi, Tamás (Farmakológia), szerző] Gyógyszerhatástani Intézet (SE / GYTK) 12 0.071 false false false Author 10012548 /api/author/10012548 Tábi Tamás (Farmakológia) Tábi Tamás true 10012548 true Tábi Tamás true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966025 /api/authorship/108966025 Szökö, Éva [Szökő, Éva (Farmakológia, gyó...), szerző] Gyógyszerhatástani Intézet (SE / GYTK) 13 0.071 false false false Author 10003174 /api/author/10003174 Szökő Éva (Farmakológia, gyógyszeranalitika) Szökő Éva true 10003174 true Szökö Éva true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 108966026 /api/authorship/108966026 Volkovová, Katarína 14 0.071428575 false true false Volkovová Katarína true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 24021301 /api/publicationidentifier/24021301 DOI: 10.3390/antiox12061221 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.3390/antiox12061221 https://doi.org/10.3390/antiox12061221 false true PublicationIdentifier 24157712 /api/publicationidentifier/24157712 WoS: 001013840500001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001013840500001 https://www.webofscience.com/wos/woscc/full-record/001013840500001 true true PublicationIdentifier 24176631 /api/publicationidentifier/24176631 Scopus: 85163817223 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85163817223 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85163817223 true true PublicationIdentifier 24021302 /api/publicationidentifier/24021302 PubMed: 37371951 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 37371951 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37371951&dopt=Abstract false true SjrRating 11379437 /api/sjrrating/11379437 sjr:D1 (2023) Scopus - Food Science ANTIOXIDANTS 2076-3921 24 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1106 /api/classificationexternal/1106 Scopus - Food Science true 1106 true D1 DIRECT true true Reference 42388147 /api/reference/42388147 1. Alberti 1998: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation., Diabet. Med., 15, p. 539, DOI: 10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S 1 10.1002/(SICI)1096-9136(199807)15:7&lt;539::AID-DIA668&gt;3.0.CO;2-S false true Reference 42388148 /api/reference/42388148 2. Balkau 1999: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)., Diabet. Med., 16, p. 442, DOI: 10.1046/j.1464-5491.1999.00059.x 2 10.1046/j.1464-5491.1999.00059.x false true Reference 42388149 /api/reference/42388149 3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285, 2486–2497., DOI: 10.1001/jama.285.19.2486 3 10.1001/jama.285.19.2486 false true Reference 42388150 /api/reference/42388150 4. Zimmet 2005: The metabolic syndrome: A global public health problem and a new definition., J. Atheroscler. Thromb., 12, p. 295, DOI: 10.5551/jat.12.295 4 10.5551/jat.12.295 false true Reference 42388151 /api/reference/42388151 5. Alberti 2009: Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity., Circulation, 120, p. 1640, DOI: 10.1161/CIRCULATIONAHA.109.192644 5 10.1161/CIRCULATIONAHA.109.192644 false true Reference 42388152 /api/reference/42388152 6. Ford 2008: Metabolic syndrome and incident diabetes: Current state of the evidence., Diabetes Care, 31, p. 1898, DOI: 10.2337/dc08-0423 6 10.2337/dc08-0423 false true Reference 42388153 /api/reference/42388153 7. Mottillo 2010: The Metabolic Syndrome and Cardiovascular Risk a Systematic Review and Meta-Analysis., J. Am. Coll. Cardiol., 56, p. 1113, DOI: 10.1016/j.jacc.2010.05.034 7 10.1016/j.jacc.2010.05.034 false true Reference 42388154 /api/reference/42388154 8. Spahis 2017: Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress., Antioxid. Redox Signal., 26, p. 445, DOI: 10.1089/ars.2016.6756 8 10.1089/ars.2016.6756 false true Reference 42388155 /api/reference/42388155 9. Vona, R., Gambardella, L., Cittadini, C., Straface, E., and Pietraforte, D. (2019). Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. Oxid. Med. Cell. Longev., 2019., DOI: 10.1155/2019/8267234 9 10.1155/2019/8267234 false true Reference 42388156 /api/reference/42388156 10. Monserrat-Mesquida, M., Quetglas-Llabrés, M., Capó, X., Bouzas, C., Mateos, D., Pons, A., Tur, J.A., and Sureda, A. (2020). Metabolic Syndrome is Associated with Oxidative Stress and Proinflammatory State. Antioxidants, 9., DOI: 10.3390/antiox9030236 10 10.3390/antiox9030236 false true Reference 42388157 /api/reference/42388157 11. Rezzani, R., and Franco, C. (2021). Liver, Oxidative Stress and Metabolic Syndromes. Nutrients, 13., DOI: 10.3390/nu13020301 11 10.3390/nu13020301 false true Reference 42388158 /api/reference/42388158 12. Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., and Assi, H.I. (2022). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci., 23., DOI: 10.3390/ijms23020786 12 10.3390/ijms23020786 false true Reference 42388159 /api/reference/42388159 13. Rochlani 2017: Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds., Ther. Adv. Cardiovasc. Dis., 11, p. 215, DOI: 10.1177/1753944717711379 13 10.1177/1753944717711379 false true Reference 42388160 /api/reference/42388160 14. Gugliucci 2022: Biomarkers of dysfunctional visceral fat., Adv. Clin. Chem., 109, p. 1, DOI: 10.1016/bs.acc.2022.03.001 14 10.1016/bs.acc.2022.03.001 false true Reference 42388161 /api/reference/42388161 15. Hachiya, R., Tanaka, M., Itoh, M., and Suganami, T. (2022). Molecular mechanism of cross-talk between immune and metabolic systems in metabolic syndrome. Inflamm. Regen., 42., DOI: 10.1186/s41232-022-00198-7 15 10.1186/s41232-022-00198-7 false true Reference 42388162 /api/reference/42388162 16. Kawai 2021: Adipose tissue inflammation and metabolic dysfunction in obesity., Am. J. Physiol. Cell. Physiol., 320, p. C375, DOI: 10.1152/ajpcell.00379.2020 16 10.1152/ajpcell.00379.2020 false true Reference 42388163 /api/reference/42388163 17. Henning 2021: Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: A review of the pathophysiology and treatment of obesity., Am. J. Cardiovasc. Dis., 11, p. 504 17 false true Reference 42388164 /api/reference/42388164 18. Zhang, Z., Zhao, L., Zhou, X., Meng, X., and Zhou, X. (2023). Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets. Front. Immunol., 13., DOI: 10.3389/fimmu.2022.1098725 18 10.3389/fimmu.2022.1098725 false true Reference 42388165 /api/reference/42388165 19. Kucharska 2020: Obesity and chronic inflammation crosslinking., Cent. Eur. J. Immunol., 45, p. 461, DOI: 10.5114/ceji.2020.103418 19 10.5114/ceji.2020.103418 false true Reference 42388166 /api/reference/42388166 20. Uribe-Querol, E., and Rosales, C. (2022). Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications. Cells, 11., DOI: 10.3390/cells11121883 20 10.3390/cells11121883 false true Reference 42388167 /api/reference/42388167 21. Zatterale, F., Longo, M., Naderi, J., Raciti, G.A., Desiderio, A., Miele, C., and Beguinot, F. (2019). Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front. Physiol., 10., DOI: 10.3389/fphys.2019.01607 21 10.3389/fphys.2019.01607 false true Reference 42388168 /api/reference/42388168 22. Ndumele 2006: Interrelationships between inflammation, C-reactive protein, and insulin resistance., J. Cardiometab. Syndr., 1, p. 190, DOI: 10.1111/j.1559-4564.2006.05538.x 22 10.1111/j.1559-4564.2006.05538.x false true Reference 42388169 /api/reference/42388169 23. Yasue 2006: Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers., Circ. J., 70, p. 8, DOI: 10.1253/circj.70.8 23 10.1253/circj.70.8 false true Reference 42388170 /api/reference/42388170 24. Sies 2020: Reactive oxygen species (ROS) as pleiotropic physiological signalling agents., Nat. Rev. Mol. Cell. Biol., 21, p. 363, DOI: 10.1038/s41580-020-0230-3 24 10.1038/s41580-020-0230-3 false true Reference 42388171 /api/reference/42388171 25. Verhaegen 2022: Oxidative Stress in Relation to Aging and Exercise., Encyclopedia, 2, p. 1545, DOI: 10.3390/encyclopedia2030105 25 10.3390/encyclopedia2030105 false true Reference 42388172 /api/reference/42388172 26. Gori 2010: Is oxidative stress a therapeutic target in cardiovascular disease?., Eur. Heart J., 31, p. 2741, DOI: 10.1093/eurheartj/ehq396 26 10.1093/eurheartj/ehq396 false true Reference 42388173 /api/reference/42388173 27. Jakubiak, G.K., Osadnik, K., Lejawa, M., Osadnik, T., Goławski, M., Lewandowski, P., and Pawlas, N. (2022). “Obesity and Insulin Resistance” Is the Component of the Metabolic Syndrome Most Strongly Associated with Oxidative Stress. Antioxidants, 11., DOI: 10.3390/antiox11010079 27 10.3390/antiox11010079 false true Reference 42388174 /api/reference/42388174 28. Suriyaprom, K., Kaewprasert, S., Putpadungwipon, P., Namjuntra, P., and Klongthalay, S. (2019). Association of antioxidant status and inflammatory markers with metabolic syndrome in Thais. J. Health Popul. Nutr., 38., DOI: 10.1186/s41043-018-0158-9 28 10.1186/s41043-018-0158-9 false true Reference 42388175 /api/reference/42388175 29. Grzebyk 2014: Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome., J. Endocrinol. Invest., 37, p. 819, DOI: 10.1007/s40618-014-0111-8 29 10.1007/s40618-014-0111-8 false true Reference 42388176 /api/reference/42388176 30. Tylutka, A., Morawin, B., Walas, Ł., Michałek, M., Gwara, A., and Zembron-Lacny, A. (2023). Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults. Sci. Rep., 13., DOI: 10.1038/s41598-022-27269-6 30 10.1038/s41598-022-27269-6 false true Reference 42388177 /api/reference/42388177 31. You 2008: The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity., J. Gerontol. A Biol. Sci. Med. Sci., 63, p. 414, DOI: 10.1093/gerona/63.4.414 31 10.1093/gerona/63.4.414 false true Reference 42388178 /api/reference/42388178 32. Chen, S.-J., Yen, C.-H., Huang, Y.-C., Lee, B.-J., Hsia, S., and Lin, P.-T. (2012). Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome. PLoS ONE, 7., DOI: 10.1371/journal.pone.0045693 32 10.1371/journal.pone.0045693 false true Reference 42388179 /api/reference/42388179 33. Mirhafez 2015: Cytokine and growth factor profiling in patients with the metabolic syndrome., Br. J. Nutr., 113, p. 1911, DOI: 10.1017/S0007114515001038 33 10.1017/S0007114515001038 false true Reference 42388180 /api/reference/42388180 34. Christiana 2016: Plasma levels of inflammatory cytokines in adult Nigerians with the metabolic syndrome., Niger. Med. J., 57, p. 64, DOI: 10.4103/0300-1652.180569 34 10.4103/0300-1652.180569 false true Reference 42388181 /api/reference/42388181 35. Padez 2016: Influence of Biochemical and Anthropometric Factors on the Presence of Insulin Resistance in Adolescents., Biol. Res. Nurs., 18, p. 541, DOI: 10.1177/1099800416648207 35 10.1177/1099800416648207 false true Reference 42388182 /api/reference/42388182 36. Choi 2007: Prevalence of the metabolic syndrome in individuals with hyperuricemia., Am. J. Med., 120, p. 442, DOI: 10.1016/j.amjmed.2006.06.040 36 10.1016/j.amjmed.2006.06.040 false true Reference 42388183 /api/reference/42388183 37. Neves, C.V.B., Mambrini, J.V.M., Torres, K.C.L., Teixeira-Carvalho, A., Martins-Filho, O.A., Lima-Costa, M.F., and Peixoto, S.V. (2019). Association of metabolic syndrome with inflammatory markers in a sample of community-dwelling older adults. Cad. Saude Publica, 35. 37 false true Reference 42388184 /api/reference/42388184 38. Vaidya 2011: Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: Multi-ethnic study of atherosclerosis., Eur. J. Clin. Nutr., 65, p. 818, DOI: 10.1038/ejcn.2011.47 38 10.1038/ejcn.2011.47 false true Reference 42388185 /api/reference/42388185 39. Huerta-Delgado, A.S., Roffe-Vazquez, D.N., Gonzalez-Gil, A.M., Villarreal-Calderón, J.R., Tamez-Rivera, O., Rodriguez-Gutierrez, N.A., Castillo, E.C., Silva-Platas, C., Garcia-Rivas, G., and Elizondo-Montemayor, L. (2020). Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. J. Diabetes Res., 2020., DOI: 10.1155/2020/1949415 39 10.1155/2020/1949415 false true Reference 42388186 /api/reference/42388186 40. Lee, C.H., Kuo, F.C., Tang, W.H., Lu, C.H., Su, S.C., Liu, J.S., Hsieh, C.H., Hung, Y.J., and Lin, F.H. (2019). Serum E-selectin concentration is associated with risk of metabolic syndrome in females. PLoS ONE, 14., DOI: 10.1371/journal.pone.0222815 40 10.1371/journal.pone.0222815 false true Reference 42388187 /api/reference/42388187 41. Ghazizadeh 2020: Association between serum cell adhesion molecules with hs-CRP, uric acid and VEGF genetic polymorphisms in subjects with metabolic syndrome., Mol. Biol. Rep., 47, p. 867, DOI: 10.1007/s11033-019-05081-2 41 10.1007/s11033-019-05081-2 false true Reference 42388188 /api/reference/42388188 42. Gurecka 2016: Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: A cross-sectional study., Glycoconj. J., 33, p. 599, DOI: 10.1007/s10719-016-9696-9 42 10.1007/s10719-016-9696-9 false true Reference 42388189 /api/reference/42388189 43. Wu, S.-S., Kor, C.-T., Chen, T.-Y., Liu, K.-H., Shih, K.-L., Su, W.-W., and Wu, H.-M. (2019). Relationships between Serum Uric Acid, Malondialdehyde Levels, and Carotid Intima-Media Thickness in the Patients with Metabolic Syndrome. Oxidative Med. Cell. Longev., 2019., DOI: 10.1155/2019/6859757 43 10.1155/2019/6859757 false true Reference 42388190 /api/reference/42388190 44. Klisic 2019: Nitric Oxide Products are not Associated with Metabolic Syndrome., J. Med. Biochem., 38, p. 361, DOI: 10.2478/jomb-2018-0035 44 10.2478/jomb-2018-0035 false true Reference 42388191 /api/reference/42388191 45. Venturini 2015: Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation., Nutr. Res., 35, p. 759, DOI: 10.1016/j.nutres.2015.06.013 45 10.1016/j.nutres.2015.06.013 false true Reference 42388192 /api/reference/42388192 46. Zeman 2013: Altered activities of antioxidant enzymes in patients with metabolic syndrome., Obes. Facts, 6, p. 39, DOI: 10.1159/000348569 46 10.1159/000348569 false true Reference 42388193 /api/reference/42388193 47. Mohorko, N., Petelin, A., Jurdana, M., Biolo, G., and Jenko-Pražnikar, Z. (2015). Elevated serum levels of cysteine and tyrosine: Early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome. Biomed. Res. Int., 2015., DOI: 10.1155/2015/418681 47 10.1155/2015/418681 false true Reference 42388194 /api/reference/42388194 48. Awadallah 2019: Waist circumference is a major determinant of oxidative stress in subjects with and without metabolic syndrome., Diabetes Metab. Syndr., 13, p. 2541, DOI: 10.1016/j.dsx.2019.07.010 48 10.1016/j.dsx.2019.07.010 false true Reference 42388195 /api/reference/42388195 49. Ziobro 2013: Oxidative damages in erythrocytes of patients with metabolic syndrome., Mol. Cell. Biochem., 378, p. 267, DOI: 10.1007/s11010-013-1617-7 49 10.1007/s11010-013-1617-7 false true Reference 42388196 /api/reference/42388196 50. Perona 2016: Predictive value of ceruloplasmin for metabolic syndrome in adolescents., Biofactors, 42, p. 163 50 false true Reference 42388197 /api/reference/42388197 51. Kim 2002: Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: A population-based study., Metabolism, 51, p. 838, DOI: 10.1053/meta.2002.33348 51 10.1053/meta.2002.33348 false true Reference 42388198 /api/reference/42388198 52. Safavi, S.M., Ziaei, R., and Maracy, M.R. (2012). Association of serum ceruloplasmin level with obesity: Some components of metabolic syndrome and high-sensitive C-reactive protein in Iran. J. Obes., 2012., DOI: 10.1155/2012/951093 52 10.1155/2012/951093 false true Reference 42388199 /api/reference/42388199 53. Sebekova 2014: Total plasma Nepsilon-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects., Clin. Chem. Lab. Med., 52, p. 139, DOI: 10.1515/cclm-2012-0879 53 10.1515/cclm-2012-0879 false true Reference 42388200 /api/reference/42388200 54. Hudson 2014: Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: The Northern Manhattan Study., Metabolism, 63, p. 1125, DOI: 10.1016/j.metabol.2014.05.011 54 10.1016/j.metabol.2014.05.011 false true Reference 42388201 /api/reference/42388201 55. Haddad, M., Knani, I., Bouzidi, H., Berriche, O., Hammami, M., and Kerkeni, M. (2016). Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect. Dis. Markers, 2016., DOI: 10.1155/2016/6248264 55 10.1155/2016/6248264 false true Reference 42388202 /api/reference/42388202 56. He, C.T., Lee, C.H., Hsieh, C.H., and Hsiao, F.C. (2014). Soluble form of receptor for advanced glycation end products is associated with obesity and metabolic syndrome in adolescents. Int. J. Endocrinol., 2014., DOI: 10.1155/2014/657607 56 10.1155/2014/657607 false true Reference 42388203 /api/reference/42388203 57. Bonassi 2015: Genetic determinants of quantitative traits associated with cardiovascular disease risk., Mutat. Res., 778, p. 18, DOI: 10.1016/j.mrfmmm.2015.05.005 57 10.1016/j.mrfmmm.2015.05.005 false true Reference 42388204 /api/reference/42388204 58. Ashwell, M., and Gibson, S. (2014). A proposal for a primary screening tool: ‘Keep your waist circumference to less than half your height’. BMC Med., 12., DOI: 10.1186/s12916-014-0207-1 58 10.1186/s12916-014-0207-1 false true Reference 42388205 /api/reference/42388205 59. Munch 1997: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA., Eur. J. Clin. Chem. Clin. Biochem., 35, p. 669 59 false true Reference 42388206 /api/reference/42388206 60. Yu 1993: Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes., Diabetes, 42, p. 594, DOI: 10.2337/diab.42.4.594 60 10.2337/diab.42.4.594 false true Reference 42388207 /api/reference/42388207 61. Richard 1992: High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent., J. Chromatogr., 577, p. 9, DOI: 10.1016/0378-4347(92)80593-F 61 10.1016/0378-4347(92)80593-F false true Reference 42388208 /api/reference/42388208 62. Cerhata 1994: Determination of ascorbic acid in blood serum using high-performance liquid chromatography and its correlation with spectrophotometric (colorimetric) determination., Ceska Slov. Farm., 43, p. 166 62 false true Reference 42388209 /api/reference/42388209 63. Hess 1991: Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high-performance liquid chromatography on reversed phase., Int. J. Vitam. Nutr. Res., 61, p. 232 63 false true Reference 42388210 /api/reference/42388210 64. Houze 2001: Simultaneous determination of total plasma glutathione, homocysteine, cysteinylglycine, and methionine by high-performance liquid chromatography with electrochemical detection., J. Clin. Lab. Anal., 15, p. 144, DOI: 10.1002/jcla.1018 64 10.1002/jcla.1018 false true Reference 42388211 /api/reference/42388211 65. Melnyk 1999: A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection., J. Nutr. Biochem., 10, p. 490, DOI: 10.1016/S0955-2863(99)00033-9 65 10.1016/S0955-2863(99)00033-9 false true Reference 42388212 /api/reference/42388212 66. Paglia 1967: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase., J. Lab. Clin. Med., 70, p. 158 66 false true Reference 42388213 /api/reference/42388213 67. Cavarocchi 1986: Superoxide generation during cardiopulmonary bypass: Is there a role for vitamin E?., J. Surg. Res., 40, p. 519, DOI: 10.1016/0022-4804(86)90093-4 67 10.1016/0022-4804(86)90093-4 false true Reference 42388214 /api/reference/42388214 68. Habig 1974: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation., J. Biol. Chem., 249, p. 7130, DOI: 10.1016/S0021-9258(19)42083-8 68 10.1016/S0021-9258(19)42083-8 false true Reference 42388215 /api/reference/42388215 69. Schosinsky 1974: Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride., Clin. Chem., 20, p. 1556, DOI: 10.1093/clinchem/20.12.1556 69 10.1093/clinchem/20.12.1556 false true Reference 42388216 /api/reference/42388216 70. Beydoun 2011: Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys., J. Nutr., 141, p. 903, DOI: 10.3945/jn.110.136580 70 10.3945/jn.110.136580 false true Reference 42388217 /api/reference/42388217 71. Kocna, P. (2023, January 13). MiniEncyklopedia Laboratorních Metod v Gastroenterologii [MiniEncyclopedia of Laboratory Methods in Gastroenterology]. Available online: http://www1.lf1.cuni.cz/~kocna/glab/glency1.htm. 71 false true Reference 42388218 /api/reference/42388218 72. Dobiasova 2001: The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))., Clin. Biochem., 34, p. 583, DOI: 10.1016/S0009-9120(01)00263-6 72 10.1016/S0009-9120(01)00263-6 false true Reference 42388219 /api/reference/42388219 73. Katz 2000: Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans., J. Clin. Endocrinol. Metab., 85, p. 2402, DOI: 10.1210/jcem.85.7.6661 73 10.1210/jcem.85.7.6661 false true Reference 42388220 /api/reference/42388220 74. Levey 2002: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification., Am. J. Kidney Dis., 39, p. S1 74 false true Reference 42388221 /api/reference/42388221 75. Sebekova 2002: Does magnesium dysbalance participate in the development of insulin resistance in early stages of renal disease?., Physiol. Res., 51, p. 605 75 false true Reference 42388222 /api/reference/42388222 76. Ridker 2003: Clinical application of C-reactive protein for cardiovascular disease detection and prevention., Circulation, 107, p. 363, DOI: 10.1161/01.CIR.0000053730.47739.3C 76 10.1161/01.CIR.0000053730.47739.3C false true Reference 42388223 /api/reference/42388223 77. Godala 2017: The risk of plasma vitamin A, C, E and D deficiency in patients with metabolic syndrome: A case-control study., Adv. Clin. Exp. Med., 26, p. 581, DOI: 10.17219/acem/62453 77 10.17219/acem/62453 false true Reference 42388224 /api/reference/42388224 78. Yubero-Serrano, E.M., Delgado-Lista, J., Peña-Orihuela, P., Perez-Martinez, P., Fuentes, F., Marin, C., Tunez, I., Tinahones, F.J., Perez-Jimenez, F., and Roche, H.M. (2013). Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp. Mol. Med., 45., DOI: 10.1038/emm.2013.53 78 10.1038/emm.2013.53 false true Reference 42388225 /api/reference/42388225 79. Giral 2008: Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome., Arterioscler. Thromb. Vasc. Biol., 28, p. 587, DOI: 10.1161/ATVBAHA.107.157891 79 10.1161/ATVBAHA.107.157891 false true Reference 42388226 /api/reference/42388226 80. Lushchak, V.I. (2012). Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions. J. Amino Acids, 2012., DOI: 10.1155/2012/736837 80 10.1155/2012/736837 false true Reference 42388227 /api/reference/42388227 81. Vítek, L., Jirásková, A., Malíková, I., Dostálová, G., Eremiášová, L., Danzig, V., Linhart, A., and Haluzík, M. (2022). Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis. Antioxidants, 11., DOI: 10.3390/antiox11112118 81 10.3390/antiox11112118 false true Reference 42388228 /api/reference/42388228 82. Creeden 2021: Bilirubin as a metabolic hormone: The physiological relevance of low levels., Am. J. Physiol. Endocrinol. Metab., 320, p. E191, DOI: 10.1152/ajpendo.00405.2020 82 10.1152/ajpendo.00405.2020 false true Reference 42388229 /api/reference/42388229 83. Wang 2013: Plasma and dietary antioxidant status as cardiovascular disease risk factors: A review of human studies., Nutrients, 5, p. 2969, DOI: 10.3390/nu5082969 83 10.3390/nu5082969 false true Reference 42388230 /api/reference/42388230 84. Glantzounis 2005: Uric acid and oxidative stress., Curr. Pharm. Des., 11, p. 4145, DOI: 10.2174/138161205774913255 84 10.2174/138161205774913255 false true Reference 42388231 /api/reference/42388231 85. Joosten 2020: Asymptomatic hyperuricaemia: A silent activator of the innate immune system., Nat. Rev. Rheumatol., 16, p. 75, DOI: 10.1038/s41584-019-0334-3 85 10.1038/s41584-019-0334-3 false true Reference 42388232 /api/reference/42388232 86. Kuwabara 2017: Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function., Am. J. Nephrol., 45, p. 330, DOI: 10.1159/000464260 86 10.1159/000464260 false true Reference 42388233 /api/reference/42388233 87. Kuwabara 2018: Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan., Int. J. Cardiol., 261, p. 183, DOI: 10.1016/j.ijcard.2018.03.045 87 10.1016/j.ijcard.2018.03.045 false true Reference 42388234 /api/reference/42388234 88. Kuwabara 2018: Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study., Hypertension, 71, p. 78, DOI: 10.1161/HYPERTENSIONAHA.117.10370 88 10.1161/HYPERTENSIONAHA.117.10370 false true Reference 42388235 /api/reference/42388235 89. Virdis 2020: Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years., Hypertension, 75, p. 302, DOI: 10.1161/HYPERTENSIONAHA.119.13643 89 10.1161/HYPERTENSIONAHA.119.13643 false true Reference 42388236 /api/reference/42388236 90. Sebekova 2020: Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese But Not in Lean Adolescents., Diabetes Metab. Syndr. Obes., 13, p. 3977, DOI: 10.2147/DMSO.S267123 90 10.2147/DMSO.S267123 false true Reference 42388237 /api/reference/42388237 91. Wong 2020: Vitamin C: A Review on its Role in the Management of Metabolic Syndrome., Int. J. Med. Sci., 17, p. 1625, DOI: 10.7150/ijms.47103 91 10.7150/ijms.47103 false true Reference 42388238 /api/reference/42388238 92. Guo, H., Ding, J., Liu, Q., Li, Y., Liang, J., and Zhang, Y. (2021). Vitamin C and Metabolic Syndrome: A Meta-Analysis of Observational Studies. Front. Nutr., 8., DOI: 10.3389/fnut.2021.728880 92 10.3389/fnut.2021.728880 false true Reference 42388239 /api/reference/42388239 93. Zhang, Y., Ding, J., Guo, H., Liu, Z., Liu, Q., Li, Y., Zhang, D., and Liang, J. (2021). Associations of Dietary and Circulating Vitamin E Level with Metabolic Syndrome. A Meta-Analysis of Observational Studies. Front. Nutr., 8., DOI: 10.3389/fnut.2021.783990 93 10.3389/fnut.2021.783990 false true Reference 42388240 /api/reference/42388240 94. Ruiz-Castell, M., Le Coroller, G., Landrier, J.F., Kerkour, D., Weber, B., Fagherazzi, G., Appenzeller, B.M.R., Vaillant, M., and Bohn, T. (2020). Micronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHES-LUX Study. Nutrients, 13., DOI: 10.3390/nu13010005 94 10.3390/nu13010005 false true Reference 42388241 /api/reference/42388241 95. Liu 2014: Higher serum carotenoid concentrations associated with a lower prevalence of the metabolic syndrome in middle-aged and elderly Chinese adults., Br. J. Nutr., 112, p. 2041, DOI: 10.1017/S000711451400316X 95 10.1017/S000711451400316X false true Reference 42388242 /api/reference/42388242 96. Ford 2003: The metabolic syndrome and antioxidant concentrations: Findings from the Third National Health and Nutrition Examination Survey., Diabetes, 52, p. 2346, DOI: 10.2337/diabetes.52.9.2346 96 10.2337/diabetes.52.9.2346 false true Reference 42388243 /api/reference/42388243 97. Senkus 2019: Lycopene and Metabolic Syndrome: A Systematic Review of the Literature., Adv. Nutr., 10, p. 19, DOI: 10.1093/advances/nmy069 97 10.1093/advances/nmy069 false true Reference 42388244 /api/reference/42388244 98. Ayala, A., Muñoz, M.F., and Argüelles, S. (2014). Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative Med. Cell. Longev., 2014., DOI: 10.1155/2014/360438 98 10.1155/2014/360438 false true Reference 42388245 /api/reference/42388245 99. Rabbani 2011: Glyoxalase in diabetes, obesity and related disorders., Semin. Cell. Dev. Biol., 22, p. 309, DOI: 10.1016/j.semcdb.2011.02.015 99 10.1016/j.semcdb.2011.02.015 false true Reference 42388246 /api/reference/42388246 100. Henning 2016: Pathways of the Maillard reaction under physiological conditions., Glycoconj. J., 33, p. 499, DOI: 10.1007/s10719-016-9694-y 100 10.1007/s10719-016-9694-y false true Reference 42388247 /api/reference/42388247 101. Miyata 1999: Alterations in non-enzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications., Kidney Int., 55, p. 389, DOI: 10.1046/j.1523-1755.1999.00302.x 101 10.1046/j.1523-1755.1999.00302.x false true Reference 42388248 /api/reference/42388248 102. Monnier 1992: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia., Diabetes, 41, p. 36, DOI: 10.2337/diab.41.2.S36 102 10.2337/diab.41.2.S36 false true Reference 42388249 /api/reference/42388249 103. Ruiz, H.H., Ramasamy, R., and Schmidt, A.M. (2020). Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease. Endocrinology, 161., DOI: 10.1210/endocr/bqz006 103 10.1210/endocr/bqz006 false true Reference 42388250 /api/reference/42388250 104. Koyama 2005: Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis., Arterioscler. Thromb. Vasc. Biol., 25, p. 2587, DOI: 10.1161/01.ATV.0000190660.32863.cd 104 10.1161/01.ATV.0000190660.32863.cd false true Reference 42388251 /api/reference/42388251 105. Uribarri 2015: Elevated serum advanced glycation end-products in obese indicate risk for the metabolic syndrome: A link between healthy and unhealthy obesity?., J. Clin. Endocrinol. Metab., 100, p. 1957, DOI: 10.1210/jc.2014-3925 105 10.1210/jc.2014-3925 false true Reference 42388252 /api/reference/42388252 106. Gugliucci 1996: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells., Diabetologia, 39, p. 149, DOI: 10.1007/BF00403957 106 10.1007/BF00403957 false true Reference 42388253 /api/reference/42388253 107. Liang 2020: The fate of dietary advanced glycation end products in the body: From oral intake to excretion., Crit. Rev. Food Sci. Nutr., 60, p. 3475, DOI: 10.1080/10408398.2019.1693958 107 10.1080/10408398.2019.1693958 false true Reference 42388254 /api/reference/42388254 108. Sebekova 2009: Plasma advanced glycation end products are decreased in obese children compared with lean controls., Int. J. Pediatr. Obes., 4, p. 112, DOI: 10.1080/17477160802248039 108 10.1080/17477160802248039 false true Reference 42388255 /api/reference/42388255 109. Bierhaus 2005: Understanding RAGE, the receptor for advanced glycation end products., J. Mol. Med., 83, p. 876, DOI: 10.1007/s00109-005-0688-7 109 10.1007/s00109-005-0688-7 false true Reference 42388256 /api/reference/42388256 110. Andersen 2016: Impact of Obesity and Metabolic Syndrome on Immunity., Adv. Nutr., 7, p. 66, DOI: 10.3945/an.115.010207 110 10.3945/an.115.010207 false true Reference 42388257 /api/reference/42388257 111. Liu 2016: Circulating Retinoic Acid Levels and the Development of Metabolic Syndrome., J. Clin. Endocrinol. Metab., 101, p. 1686, DOI: 10.1210/jc.2015-4038 111 10.1210/jc.2015-4038 false true Reference 42388258 /api/reference/42388258 112. Choi 2007: Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome., Diabetes Res. Clin. Pract., 75, p. 235, DOI: 10.1016/j.diabres.2006.06.019 112 10.1016/j.diabres.2006.06.019 false true Reference 42388259 /api/reference/42388259 113. Srikanthan 2016: Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population., Int. J. Med. Sci., 13, p. 25, DOI: 10.7150/ijms.13800 113 10.7150/ijms.13800 false true Reference 42388260 /api/reference/42388260 114. Zhang, J. (2022). Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev. Cardiovasc. Med., 23., DOI: 10.31083/j.rcm2302073 114 10.31083/j.rcm2302073 false true Reference 42388261 /api/reference/42388261 115. Salmi 2019: Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation., Antioxid. Redox Signal., 30, p. 314, DOI: 10.1089/ars.2017.7418 115 10.1089/ars.2017.7418 false true Reference 42388262 /api/reference/42388262 116. Witkowska 2004: Soluble intercellular adhesion molecule-1 (sICAM-1): An overview., Eur. Cytokine Netw., 15, p. 91 116 false true Reference 42388263 /api/reference/42388263 117. Jeon 2016: Chapter Five—Leukocytes Crossing the Endothelium: A Matter of Communication., International Review of Cell and Molecular Biology, Volume 322, p. 281, DOI: 10.1016/bs.ircmb.2015.10.005 117 10.1016/bs.ircmb.2015.10.005 false true /api/publication/34010976 Šebeková Katarína et al. Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-To-45-Year-Old Females: A Cross-Sectional Study. (2023) ANTIOXIDANTS 2076-3921 12 6<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" >Šebeková Katarína ✉ </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Staruchová Marta </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Mišľanová Csilla </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Líšková Aurélia </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Horváthová Mira </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Tulinská Jana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Lehotská Mikušová Miroslava </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Szabová Michaela </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Gurecká Radana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Koborová Ivana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Csongová Melinda </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10012548"><a href="/gui2/?type=authors&mode=browse&sel=10012548" target="_blank">Tábi Tamás (<span class="authorship-author-name">Tábi Tamás</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003174"><a href="/gui2/?type=authors&mode=browse&sel=10003174" target="_blank">Szökö Éva (<span class="authorship-author-name">Szökő Éva</span> <span class="authorAux-mtmt"> Farmakológia, gyógyszeranalitika</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/Gyógyszerhatástani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Volkovová Katarína </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34010976" target="_blank">Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-To-45-Year-Old Females: A Cross-Sectional Study</a></div> <div> <span class="journal-title">ANTIOXIDANTS</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2076-3921">2076-3921</a>)</span>: <span class="journal-volume">12</span> <span class="journal-issue">6</span> <span class="page"> Paper 1221. 19 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.3390/antiox12061221" target="_blank" href="https://doi.org/10.3390/antiox12061221"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001013840500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001013840500001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85163817223" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85163817223"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="37371951" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37371951&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Food Science&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Biochemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Clinical Biochemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Physiology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cell Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 13</span> | Független: 12 | Függő: 1 | Nem jelölt: 0 | WoS jelölt: 11 | Scopus jelölt:&nbsp;10 | WoS/Scopus jelölt:&nbsp;12 | DOI jelölt:&nbsp;12 </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 34010976</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2023.07.18. 13:18 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) </div> </div></div>